Evaluating safety and ethical implications of androgenetic alopecia treatments: A comparison of direct-to-consumer platforms and dermatologist visits
Journal of the American Academy of Dermatology · 2025-04 · 92 (4) · 960-961
DOI: 10.1016/j.jaad.2024.12.005 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of the American Academy of Dermatology, 2025-04. Verfasst von Michael M Ong und 1 weiteren Autor:innen. Beteiligte Einrichtung: MD Program, Weill Cornell Medical College, New York, New York. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MD Program, Weill Cornell Medical College, New York, New York.
- Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.
Zitieren
APA
Ong, M. M., & Lipner, S. R. (2025). Evaluating safety and ethical implications of androgenetic alopecia treatments: A comparison of direct-to-consumer platforms and dermatologist visits. Journal of the American Academy of Dermatology, 92(4), 960-961. https://doi.org/10.1016/j.jaad.2024.12.005
Vancouver
Ong MM, Lipner SR. Evaluating safety and ethical implications of androgenetic alopecia treatments: A comparison of direct-to-consumer platforms and dermatologist visits. Journal of the American Academy of Dermatology. 2025;92(4):960-961. doi:10.1016/j.jaad.2024.12.005
BibTeX
@article{Ong2025,
author = {Ong, Michael M and Lipner, Shari R},
title = {Evaluating safety and ethical implications of androgenetic alopecia treatments: A comparison of direct-to-consumer platforms and dermatologist visits},
journal = {Journal of the American Academy of Dermatology},
year = {2025},
volume = {92},
number = {4},
pages = {960--961},
doi = {10.1016/j.jaad.2024.12.005}
}
EUVIMED